Spartikus Rex, on 08 November 2011 - 03:23 PM, said:
It is much stronger than it used to be. I'd have a zero tolerance policy on it. Why should people who become ill for no reason have to compete for limited help with those who have caused their illness themselves?
Mmmm, By that reasoning why should the able support those with disabilities at all. I mean, where does such rational end?
Cannabis is stronger today but that is precisely because of its illegality. The illegal market leads to stronger crosses whereas a regulated market could reduce harm by controlling the level of thc/cbd etc. The evidence states that the most vulnerable group in regard to cannabis are the young/teenagers. Yet again, an unregulated/illegal market empowers drug dealers whilst we hand the young into their hands. I'm all for sensible harm reduction.
In regard to the original question, my answer would be No. The truth is in recent times it would be hard to find anyone who doesn't understand the associated harms and risks. Many drug users or dual diagnosis patients come from backgrounds of abuse or trauma and self hate/destruction is a big part of any serious addiction. With this in mind I do feel that Rethink and other similar services may have a skewed view on this issue due to the backgrounds of their client group. Cannabis is class 'B' in spite of no related deaths and 3 million users in the UK. The reason its class 'B' is not because of related deaths but because of associated risks and social harms such has mental health issues. The message is very clear.
Ex heroin addicts become alcoholics, coke heads become pot heads etc. This cycle of self destruction is about the symptom of addiction, not the drug itself. A good starting question would be - If mental health is hell, what would cause a person to wilfully inflict themselves to such a hell? How deep must problems be or how hard must reality be for a person to chose insanity.? Whilst informing people of harm is good I feel in most cases the real underlying issues can be to easily negated by a focus on this or that drug.